n,n-dimethyltryptamine has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borbély, E; Bozsó, Z; Fülöp, L; Penke, B; Schuster, I; Szögi, T; Varga, V | 1 |
1 other study(ies) available for n,n-dimethyltryptamine and Alzheimer Disease
| Article | Year |
|---|---|
Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Mice; N,N-Dimethyltryptamine; Neurogenesis; Neuroinflammatory Diseases; Peptide Fragments; Receptors, sigma; Sigma-1 Receptor | 2022 |